SPY424.48-0.78 -0.18%
DIA343.41-0.89 -0.26%
IXIC14,072.86-101.29 -0.71%

Heron Therapeutics Q1 EPS $(0.58) Down From $(0.57) YoY, Sales $20.00M Down From $25.40M YoY

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.58) per share. This is a 1.75 percent decrease over losses of $(0.57) per share from the same period last year. The company reported $20.00 million in

05/10/2021 08:43
Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.58) per share. This is a 1.75 percent decrease over losses of $(0.57) per share from the same period last year. The company reported $20.00 million in sales this quarter. This is a 21.26 percent decrease over sales of $25.40 million the same period last year.